Ovid Therapeutics OVID
NASDAQ OVID
$2.38 -0.05 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Return on Assets [ROA] (2017 - 2026)

Updated

Ovid Therapeutics (OVID) posted Return on Assets [ROA] of -15.08% for Q2 2026, up 32.92 percentage points from -48.00% a year earlier but down 2.24 percentage points from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Ovid Therapeutics' Return on Assets [ROA] came in at -14.33%, up 8.06 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +89.06 percentage points (FY2020 to FY2025).
  • In prior years, Ovid Therapeutics' Return on Assets [ROA] was -22.38% in FY2024 (+12.59 pp), -34.98% in FY2023 (-4.00 pp), -30.97% in FY2022 (-121.80 pp) and 90.83% in FY2021 (+194.21 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -51.43% in Q3 2025 to a high of 61.17% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of +5.14 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2021, with a gain of 171.05 percentage points; the weakest was Q1 2022, with a drop of 109.32 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -12.84% (Q1 2026), -16.22% (Q4 2025) and -51.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Ovid Therapeutics 448.96 Mn 80.98 Mn - -15.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.08%
Mar 31, 2026 -12.84%
Dec 31, 2025 -16.22%
Sep 30, 2025 -51.43%
Jun 30, 2025 -48.00%
Mar 31, 2025 -28.73%
Dec 31, 2024 -27.13%
Sep 30, 2024 -29.45%
Jun 30, 2024 -23.83%
Mar 31, 2024 -36.77%
Dec 31, 2023 -38.91%
Sep 30, 2023 -37.14%
Jun 30, 2023 -35.22%
Mar 31, 2023 -34.43%
Dec 31, 2022 -33.82%
Sep 30, 2022 -40.11%
Jun 30, 2022 -36.96%
Mar 31, 2022 -35.93%
Dec 31, 2021 61.17%
Sep 30, 2021 59.66%
API Access

Ovid Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OVID&period=max&api_key=YOUR_API_KEY